News
Seeing critical anatomy clearly during surgery can make all the difference. A fluorescence imaging technology developed by NIH inventors is moving closer to clinical testing through an exclusive patent license with Optosurgical, LLC. The license gives the Maryland-based surgical imaging company U.S
NIH’s Steven Ferguson and Michael Salgaller have co-written a chapter in the recently released book, Science for a Better Tomorrow. Their chapter, The U.S. National Institutes of Health: Inspiring Innovation in Biomedicine and Health, is an insightful read for anyone who is looking to better
Two NIH Technology Transfer experts are headed to Philadelphia for the BioTechX conference taking place September 16-17, 2025. Steve Ferguson, Special Advisor in the NIH Office of Technology Transfer will be speaking on the Partnering with NIH in the Rare Disease Landscape panel on September 16th
Register for a free NIH technology webinar to learn about a potential, novel treatment for Triple Negative Breast Cancer (TNBC). William Reinhold and his team at the National Cancer Institute repurposed two separate therapeutic compounds ─ acetalax and bisacodyl (both previously used as laxatives) ─